CURRICULUM VITAE
RICHARD F. LABASKY, MD, MBA
May 1, 2001
Office
Address: 9600 S. 1300 E., Suite 301, Sandy,
UT 84094
801-501-5300; 801-501-5350 (fax)
Internet
Address: richard.labasky@hsc.utah.edu
Baccalaureate U.S.
Air Force Academy, Colorado Springs, CO 1971-72
Webb
Institute of Naval Architecture, Glen Cove,
N.Y.;
B.S. Naval Architecture and Marine
Engineering,
1976 1972-76
MD University of Texas Medical Branch
(UTMB) at
Galveston,
TX; M.D. with Honors, 1983 1979-83
Residency
General Surgery, University
of Utah Medical
Center 1983-85
Urology, University of
Utah Medical Center 1985-88
Fellowship
Urodynamics, Female
Urology and Prosthetics with
G.E.
Leach, M.D.; Kaiser Permanente Medical
Center, Los Angeles, CA 1988-89
Masters University
of Utah; Masters of Business Administration,
with
Honors, 1997 1995-1997
Board Certified Urology 1991
Recertified 1998
PROFESSIONAL EXPERIENCE
Project Engineer and Research Scientist, Sun
Shipbuilding &
Dry Dock Co., Pennsylvania 1976-1979
Assistant Professor of Surgery, Division of
Urology, University
of Utah School of Medicine 1989-1999
External Consultant/Staff Positions
Staff
Physician, Veteran's Affairs Medical Center 1989-1999
Consultant,
Optimed Medical Systems 1992,
2000
Medical Reviewer, Utah Peer Review
Organization 1993-Present
Member,
University Hospital Consortium (UHC) Technical
Assessment
Program Committee on Benign Prostatic Hyperplasia 1993
Chairman,
Utah PRO Study Group on Prostate Cancer 1993
Chairman,
Utah PRO Study Group on BPH Management 1994
Consultant/Guest
Editor, Journal of Urology 1995-Present
Consultant,
VIVUS, Inc. 1996-1999
Consultant,
CIGNA Healthcare of Utah 1997-Present
Consultant,
Blue Cross Blue Shield of Utah 1997-Present
Consultant, Alza Pharmaceuticals 2000-Present
RESEARCH AWARDS
1. A sixteen-week
double-blind placebo-controlled dose-response study using Doxazosin tablets for
the treatment of benign prostatic hyperplasia in patients with mild to moderate
essential hypertension. 1990-1991. Pfizer Pharmaceuticals; Contract.
Co-Investigator.
2. A phase II
dose-finding placebo-controlled study of four dose levels of YM617 in patients
with the signs and symptoms of benign prostatic hyperplasia. 1991-1992.
Yamanouchi Pharmaceuticals; Contract. Principal Investigator.
3. A double-blind,
randomized, placebo-controlled, dose ranging study of Atamestane (100 mg/day,
25 mg/day) to evaluate the efficacy, safety and endocrinological effects in
symptomatic patients with benign prostatic hyperplasia (BPH). 1991-1993. Berlex
Laboratories, Inc.; Contract. Principal Investigator.
4. A phase II dose
ranging efficacy study of oral Zanoterone, a new steroidal androgen receptor
antagonist, in men with symptomatic benign prostatic hyperplasia. 1991-1993.
Pfizer; Contract. Principal Investigator.
5. A double-blind,
placebo-controlled, randomized, two-way crossover, multicenter study evaluating
Levsin-SL in influencing volume of urine loss in incontinent women. 1993.
Schwarz Pharma; Contract. Principal Investigator.
6. A double-blind
randomized placebo-controlled, multicenter study to investigate the long-term
effects of Finasteride (MK-906) in patients with benign prostatic hyperplasia.
1992 - Present. Merck; Contract. Principal Investigator.
RESEARCH AWARDS (Continued)
7. A limited study
of percutaneous thermometry using the BSD MU-100 transurethral microwave
applicator. 1994. BSD, Inc. Principal Investigator.
8. Evaluation of
the safety and efficacy of Alprostadil administered by MUSE (Medicated Urethral
System for Erection). 1994. VIVUS, Inc.; Contract. Principal Investigator.
9. Evaluation
of the safety and efficacy of MUSE (Alprostadil) plus the ACTIS venous flow
controller in men with erectile dysfunction. 1997. VIVUS, Inc., Contract.
Principal Investigator.
10.
Evaluation of
hyperthermia for the treatment of benign prostatic hyperplasia (BPH) delivered
using the MU-1000. 1997. Thermatrx, Inc.; Contract. Principal
Investigator.
11.
A
multi-center, randomized, double-blind, dose-titration study of the effect of
oral (Ditropan) versus transdermal (TheraDerm) oxybutynin in patients with urge
incontinence. 1997. Theratech; Contract. Principal Investigator.
12.
An
open-label study to evaluate patient acceptance and safety of OROS oxybutynin
chloride in urge urinary incontinence.
1998. Alza Pharmaceuticals, Contract.
Principal Investigator.
13. A
multicenter, double-blind study to compare the safety and efficacy of
levofloxacin to that of ciprofloxacin in the treatment of chronic
prostatitis. 2000. Ortho-McNeil
Pharmaceuticals; Contract. Principal Investigator.
14. The
safety and tolerability oxybutyin chloride (Ditropan XL, Ditropan syrup and
Ditropan tablets) in the treatment of detrusor hyperreflexia due to neurogenic
conditions in children aged 6-15 years. 2001. Alza Pharmaceuticals; Contract.
Investigator.
SCHOLASTIC HONORS
Alpha
Omega Alpha Honor Society, University of Texas Medical Branch 1982
Jack
Langley Memorial Award/Leadership and Service, University of Texas
Medical Branch - Phi Rho Sigma Medical
Society 1982
Finalist,
Gold Headed Cane Award, University of Texas Medical Branch 1983
Herman
Barnett Award for Excellence in Surgery and Anesthesiology,
University of Texas Medical Branch 1983
Dean’s
Scholar, University of Utah 1997
Phi
Kappa Phi Honor Society, University of Utah 1997
Beta
Gamma Sigma Honor Society, University of Utah 1997
ADMINISTRATIVE EXPERIENCE
University of Utah
Member, University of Utah Quality
Improvement Committee 1990-1996
Chairman,
University Senate Nomination Committee 1991
Chief,
Urology Section, Veteran's Affairs Medical Center 1992-2000
Director,
Quality Improvement Activities, Division of Urology 1993-2000
Director, Conference and Lecture Program,
Division of Urology 1991-2000
Member,
University Graduate Medical Education Committee 1993-2000
Member, Faculty Practice Organization,
Finance & Systems Committee 1997-2000
American Urological Association
(AUA)
Facilitator,
Bladder Cancer Panel of Practice Parameters, Standards
and Guidelines Committee 1989-1999
Recipient,
John A. Hartford Foundation Grant for Practice Parameters
Workshop participation 1990
Delegate,
AMA Young Physicians Section for AUA 1990-1994
Member,
AUA Committee on Young Urologists 1992-1996
Member,
Audit Committee of Western Section- AUA 1996
Member, Health Policy Committee of
Western Section- AUA 2000-2001
Medical Associations
Member,
American Medical Association (AMA) Council on Long-Range
Planning and Development 1986-89
Delegate, AMA Resident Physician Section 1983-89
Member, Utah Medical Association (UMA)
Board of Trustees 1985-1997,
1998-Present
Delegate, Utah Medical Association (UMA)
House of Delegates (HOD) 1984-Present
Chairman, UMA Young Physicians Section 1989-90
Delegate, AMA Young Physicians Section
for AUA 1990-1994
Chairman, UMA HOD Reference Committee 1991
Chairman, UMA HOD Tellers Committee 1992
Chairman, Utah Urological Association 1992-1997
Member,
UMA Task Force for Medical Guidelines for Functional Ability
in the Workplace 1993-1994
Member, AMA Graduate Medical Education
Advisory Committee 1994-1997
Chairman, UMA Council on Government and
Legislative Affairs 1994-1997
Chairman, UMA Third Party Relations
Committee 1997-Present
Vice Speaker, UMA House of Delegates 1998-2000
Speaker, UMA House of Delegates 2000-Present
Member, UMA Executive Committee 2000-Present
PROFESSIONAL COMMUNITY
ACTIVITIES
Utah State Chapter National
Multiple Sclerosis Society,
Professional Advisory Committee, Member 1991-Present
Phi Rho Medical Society
(A professional service and social society for medical
students and physicians.)
Member, International Board of Trustees 1984-1992
Vice President - United States 1992-1994
President 1994-1997
MEMBERSHIP
IN PROFESSIONAL SOCIETIES
Phi Rho Sigma Medical Society 1979-Present
Utah Medical Association 1983-Present
American Medical Association 1983-Present
Utah Urological Association 1989-Present
Urodynamic Society/Society for Urodynamics
& Female Urology 1991-Present
American Urological Association 1993-Present
Society for the Study of Impotence 1997-Present
BIBLIOGRAPHY
Kaplan,S.,
Garvin, D., Gilhooly, P., Koppel, M., Labasky, R., et. Al. The impact of baseline symptom severity of
future risk of BPH-related outcomes and long-term response to Finasteride. Urology 1999. In press.
Padman-Nathan,
H., Hellstrom, W., Kaiser, F., Labasky, R., Lue, T., et.al.: Treatment of men
with erectile dysfunction with transurethral alprostadil. New England Journal of
Medicine 336:1-7, 1997.
REVIEWS IN JOURNALS
Labasky,
R.F.: 1998 Guest Editorial: Maybe we can do better for more- New insights on
surgical candidates and techniques for incontinence surgery. Journal of Urology.
160:763.
Labasky,
R.F.: 1995. Guest Editorial: Neurogenic bladder. Journal of Urology.
153:1467-1468.
Labasky,
R.F.: 1995. Practical urodynamics in the management of the neurogenic
bladder. Contemporary Urology.
January:17-29.
Labasky,
R.F., Leach, G.E.: 1991. Spinal cord injury and sacral arc denervation in the
female. G. Leach, Ed. Problems in
Urology: Female Urology. 5(1):155-170.
Labasky,
R.F., Leach, G.E.: 1990. Vaginal prolapse and other pathology complicating
urinary incontinence. G. Webster, Ed. Problems in Urology:Urinary
Incontinence. 4(1):
54-66.
Labasky,
R.F., Leach, G.E.: 1990. Prevention and management of female urinary fistulae.
P. Norton, Ed. Clinical Obstetrics and Gynecology.
33(2):382-91.
Leach,
G.E., Labasky, R.F.: 1989. Surgical crafts:Bone fixation technique for
transvaginal needle suspension. Urologic Clinics of North
America. 16(1):175-182.
Leach,
G.E., Labasky, R.F.: 1989. Urethral diverticulectomy in women. Contemporary
Urology. April/May:29-36.
Leach,
G.E., Labasky, R.F.: 1989. Vaginal flap technique for repairing urethral
diverticula. Contemporary OBGYN. 34(1):75-87.
Labasky,
R.F., Smith, J.A.: 1988. Management of
pain and other symptoms of advanced prostate cancer. Seminars in Urology. 4(4):311-21.
Labasky,
R.F.: Ocean Thermal Energy Conversion (OTEC) plants on ocean drilling
platforms: A design and feasibility study.
Senior thesis published at Webb Institute of Naval Architecture, May
1976.
BOOKS AND BOOK CHAPTERS
Labasky,
R.F.: 1999. Urinary incontinence and
the pelvic floor. Female Pelvic
Reconstructive Surgery.
S. Stanton, P. Zimmern, Eds. Springer-Verlag.
In press.
Labasky,
R.F.: 1997. Endoscopic Evaluation. Urinary Incontinence. P. O'Donnell, Ed. Mosby- Year Book, Inc.,
115-122.
Labasky,
R.F.: 1995. Treatment of post-prostatectomy incontinence and impotence. Medical and Surgical Management
of Prostate Cancer. R.G.
Middleton, Ed. Igaku-Shoia Medical Publishers, 130-142.
Labasky,
R.F.: 1995. Urodynamics and Evaluation of the Incontinent Patient. Clinical Urologic Practice.
B. Stein, J. Smith, A. Caldamone, Eds. W.W. Norton & Co., 551-578.
Labasky,
R.F., Leach, G.E.: 1993. Diseases of the urethra. Gynecologic and
Obstetric Urology. H. Buchsbaum, J. Schmidt, Eds. W.B. Saunders
Co., 561-580.
Labasky,
R.F.: 1992. Urodynamics. High Tech Urology - Technologic innovations and
their clinical applications. J.
Smith, Ed. W.B. Saunders Co., 140-188.
Labasky,
R.F., Leach, G.E.: 1990. Repair of vesicovaginal fistulas. J. Fowler, Ed.
Manual of Urologic Surgery.
Little, Brown and Co.
Labasky,
R.F., Leach, G.E.: 1990. Failure of operations for stress incontinence:
Evaluation and Treatment. E. McGuire, Ed. Advances in Urology.
Yearbook Medical Publishers, 107-126.
Labasky,
R.F. November, 2000. One-year, prospective open-label trial of
controlled-release oxybutynin for overactive bladder in a community-based
population. Western Section- American
Urological Association.
Labasky,
R.F., Leach, G.E. September, 1999. Twelve month experience with once-a-day
extended –release oxybutynin in a community-based population treated for
overactive bladder. Western Section -
American Urological Association.
Labasky,
R.F., Lowe, C.A. September, 1999. Cadaveric fascia for the pubovaginal sling:
Outcomes with a minimum of two years follow-up. Western Section – American Urological Association.
Labasky,
R.F., Lowe, C.A. September, 1999. Successful use of cadaveric fascia lata for
repair of high grade midline defect cystoceles. Western Section – American Urological Association.
Labasky,
R.F., Leach, G.E., Antoci, J. August,
1999. Long-term experience with
once-a-day extended release oxybutynin in a community-based population treated
for overactive bladder. International Continence Society.
Nelson,
R.P., Barada. K.H., Costabile, A., Labasky, R.F., Lewis, R.W., et. al.: May
1999. Does renewed sexual activity increase cardiac morbidity?: Metanalysis of
the experience with MUSE (alprostadil).
American Urological Association.
Labasky,
R.F., Spivak, A.P., and the MUSE Study Group.
June 1998. Transurethral
alprostadil for the treatment of erectile dysfunction: Two-year safety update.
American Urological Association.
Labasky,
R.F., et. al.: September 1997.
Transurethral alprostadil for the treatment of erectile dysfunction:
long-term safety profile. Western
Section - American Urological Association.
Labasky,
R.F., Soper, T.A.: April 1997. Reduction of patient morbidity and cost using
frozen cadaveric fascia lata for pubovaginal sling. American Urological
Association.
Soper,
T.A., Labasky, R.F.: August, 1996. Pubovaginal sling using cadaveric fascia.
Western
Section-American Urological Association.
Padma-Nathan,
H, Anderson, R.G., Brosman, S.A., Ferrigni, R.G., Govier, F.E., Labasky,
R.F.,
et. al.: August, 1996. Restoration of erectile function by transurethral
alprostadil improves the quality of life for patients and their partners. Western Section-American Urological
Association.
Milam,
D.F., Labasky, R.F.: May, 1996. Autoaugmentation (Partial detrusor myomectomy)
for incontinence due to detrusor hyperreflexia and detrusor instability. American Urological Association.
ABSTRACTS
(Continued)
Labasky,
R.F., Padma-Nathan, H., Gesundheit, N., et. al.: November, 1995. Preliminary
results of a multicenter, double-blind, placebo-controlled trial of
transurethral alprostadil in men with complete erectile dysfunction. Western Section-American Urological
Association.
Labasky,
R.F.: November, 1995. Factors
predisposing to retention after pubovaginal sling. Western Section-American Urological Association.
Labasky,
R.F.: November, 1995. Pushing the
envelope- Successful use of collagen injections in men with incontinence due to
severe pelvic trauma or incompetent efferent valves of continent urinary
diversion. Western Section-American
Urological Association.
Zobell,
L.R., Labasky, R.F.: August, 1994. The myriad presentations of
neurofibromatosis in the urinary tract. Western Section-American Urological
Association.
King,
D., Labasky, R.F.: August, 1994. Patient preference in selection of treatment
for impotence. Western Section-American Urological Association.
Labasky,
R.F., Snow, B.W., Cartwright, P.C.: August, 1994. Results of autoaugmentation
(partial detrusor myomectomy) in adults with detrusor instability and urinary
incontinence. Western Section-American Urological Association.
Labasky,
R.F., Poulson, L., Jackson, T.: August, 1994. Small area analysis of rate of
radical prostatectomy in Utah. Western Section-American Urological Association.
Labasky, R.F.:
November, 1993. Bladder outlet obstruction in pre-transplant patients with
diabetic nephropathy. Western Section-American Urological Association.
Labasky,
R.F.: November, 1993. Successful use of the Wolf 2300 piezoelectric
extracorporeal shock wave lithotriptor in a patient with an implanted automatic
antitachycardia pacemaker, cardioverter,
defibrillator. Western Section-American Urological Association.
Labasky,
R.F.: October, 1992. Eosinophilic cystitis. Western Section-American Urological
Association.
Labasky,
R.F.: October, 1992. The Mitrofanoff principle in quadriplegic patients.
Western
Section-American
Urological Association.
Labasky,
R.F., Leach, G.E.: May, 1990. The urodynamic evaluation and management of patients
with sacral arc denervation. Urodynamics Society 12th Annual Symposium.
Leach,
G.E., Labasky, R.F.: March, 1989. Repair of urethrovaginal fistulas complicated
by stress urinary incontinence. Film, Western Section-American Urological
Association.
Labasky,
R.F., Leach G.E.: March, 1989. Urodynamic evaluation and management of patients
with sacral arc denervation. Western Section-American Urological
ABSTRACTS (Continued)
Association.
Labasky,
R.F., Leach, G.E.: March, 1989. Urodynamic evaluation and management of
traumatic spinal cord injury patients. Western Section-American Urological
Associations.
Middleton,
R.G., Labasky, R.F.: March, 1989. Radical prostatectomy with proven negative
pelvic lymph nodes - ten year follow-up. Western Section-American Urological
Association.
Labasky,
R.F., Middleton, R.G., Smith, J.A.: May, 1988. Patient survival ten years after
radical prostatectomy for localized adenocarcinoma of the prostate. Society of University Urology Residents.
Labasky,
R.F., Snow, B.W.: July, 1986. Vesicoureteral reflux. Western Section-
American
Urological Association.
INVITED CME LECTURESHIPS
Labasky,
R.F.: September 2000. Update on therapy for erectile dysfunction. Veterans
Affairs Medical Center. Helena, MT.
Labasky,
R.F.: April 1999. MUSE therapy for
erectile dysfunction. Royal College of
Physicians of Thailand Annual Meeting.
Thailand.
Labasky,
R.F.: April 1999. The benign and malignant prostate and new diagnostic and
treatment tools for common diseases.
Ogden, Surgical-Medical Society Annual Medical Meetings. Ogden, UT.
Labasky,
R.F.: April 1999. Pills, pellets, pumps and punctures – An update on the
treatment of erectile dysfunction.
Ogden Surgical Medical Society Annual Medical Meeting. Ogden, UT.
Labasky,
R.F.: March 1999. Management of male impotence. University of Utah Family
Practice Refresher Course. Salt Lake
City, UT
Labasky,
R.F.: February 1999. New management approaches for incontinence. Northern Nevada OB-Gyn Society. Reno, NV.
Labasky,
R.F.: February 1999. Prostate and other genitourinary diseases in older
men. Aging in Men and Women – Current
Health Care Issues Program. Department
of Veteran’s Affairs. Reno, NV.
Labasky,
R.F.: February 1999. Incontinence: Diagnosis and treatment for the primary care
physician-Non-surgical treatments. Nevada Academy of Family Physicians Annual
CME Meeting. Lake Tahoe, NV.
Labasky,
R.F.: January 1999. Practical treatment strategies in urology: Erectile
dysfunction. AUA Office of Education Course. Park City, UT.
Labasky,
R.F.: January 1999. Practical treatment strategies in urology: Incontinence.
AUA Office of Education Course. Park City, UT.
Labasky,R.F.:
December 1998. Safety considerations in erectile dysfunction management. Hong
Kong Urological Association. Hong Kong.
Labasky,
R.F.: December 1998. Erectile dysfunction – Update on safety of MUSE.
Philippine Urological Association. Manila.
Labasky,
R.F.: December 1998. Update on safety of MUSE therapy. Malaysian Urological
Conference. Malaysia.
Labasky,
R.F.: December 1998. Update on safety of MUSE therapy. Korean Urological
Society, Seoul.
INVITED CME LECTURESHIPS (Continued)
Labasky,
R.F.: September 1998. Urology updated
for the internist. 1998 Utah Chapter
American College of Physicians Scientific Meeting. Salt Lake City, UT.
Labasky,
R.F.: August 1998. Erectile
dysfunction: strategies for effective Communication and Patient Management for
the Primary Care Physician. Park City,
UT.
Labasky,
R.F.: June 1998. Pills, pellets, pumps
and punctures:Update on erectile dysfunction.
Twenty-Second Annual Castle Country Medical Symposium. Price, UT.
Labasky,
R.F.: April 1998. Prostate and urinary
disease in older men. Seventh Annual National VA Geriatric
Conference. Salt Lake City, UT.
Labasky,
R.F.: March 1998. New treatment options
for male impotence: What gynecologists should know. Thirty-Ninth Annual Ob-Gyn Update. Park City, UT.
Labasky,
R.F.: January 1998. Recent advances in urology. American Urological Association; Snowbird,
UT.
Labasky,
R.F.: September 1997. Panelist - ATechniques of urethral slings.@ Western Section - American Urological
Association.
Labasky,
R.F.: June, 1997. Medical management for BPH: BPH and other urologic
disorders. A Primary Care Perspective;
Lehi, UT.
Labasky,
R.F.: June, 1997. New therapies for erectile dysfunction. San Diego Urological Society, San Diego, CA.
Labasky,
R.F.: June, 1997. Emerging therapy for
erectile dysfunction. Hong Kong
Urological Society, Hong Kong, China.
Labasky,
R.F.: August, 1996. Benign prostatic hypertrophy (BPH): Preventive Medicine-
The New Paradigm in Health Care; Salt Lake City, UT.
Labasky,
R.F.: May, 1995. Innovations in the diagnosis and treatment of benign prostatic
hyperplasia; Salt Lake City, UT.
Labasky,
R.F.: July, 1994. Urinary incontinence: Update in internal medicine/primary
care for the internist.
Labasky,
R.F.: November, 1993. Practical urodynamics. Postgraduate course. Western
Section-American Urological Association.
Labasky,
R.F.: November, 1993. Non-invasive management of erectile dysfunction.
Postgraduate Course, Western Section-American Urological Association.
Labasky,
R.F.: October, 1993. TURP and TUIP. Postgraduate Course, Clinical
Congress-American College of Surgeons.
INVITED CME LECTURESHIPS (Continued)
Labasky,
R.F.: July, 1993. Bladder and impotence management, management issues in
multiple sclerosis. Department of
Neurology, University of Utah and Utah State Chapter of the National Multiple
Sclerosis Society, Salt Lake City, UT.
Labasky,
R.F.: March, 1993. Urologic guide to the neurogenic bladder. Western
Intermountain Neurological Organization Meeting; Salt Lake City, UT.
Labasky,
R.F.: March, 1993. Update on prostate cancer screening and management of benign
prostatic hyperplasia. National Conference - Association of Military
Osteopathic Physicians and Surgeons, San Diego, CA.
Labasky,
R.F.: May, 1992. Management of urinary incontinence in the female. Instructional Course, American Urological
Association Annual Meeting.
Labasky,
R.F.: July, 1991. Non-prosthetic advances in the treatment of erectile
dysfunction. Postgraduate Course,
Western Section American Urological Association.
Labasky,
R.F.: May, 1991. Incontinence-Diagnosis and treatment by all physicians. Ogden Surgical-Medical Society Annual Meeting.
Labasky,
R.F.: May, 1991. The treatment of BPH today-The demise of the TURP? Ogden Surgical-Medical Society Annual
Meeting.
Labasky,
R.F.: March, 1991. Update on impotence, human sexuality, and spinal cord
injury. Continuing Medical Education
Conference, University of Utah Medical Center.
Labasky,
R.F.: September, 1989. Urinary incontinence in the geriatric patient.
University of Utah CME Program - Current Dilemmas in Geriatrics.
Labasky,
R.F.: March, 1989. Case presentations; Discussion coordinator. Vaginal surgery
for the urologist. Post graduate Course, Western Section - American Urological
Association.
Labasky,
R.F.: March, 1989. Urinary incontinence: Female and male. California Medical
Association, Western Scientific Assembly.
Labasky,
R.F.: January, 1989. History, physical examination and endoscopy in the
evaluation of female incontinence. Southern California Kaiser Permanente
Medical Group, Annual Urology Symposium.
GRAND ROUNDS
Labasky,
R.F. June 1998. New therapies for
erectile dysfunction. Medical Staff
Grand Rounds, Dixie Regional
Medical Center, St. George, UT.
Labasky,
R.F. June 1998. New therapies for
erectile dysfunction. Medical Staff
Grand Rounds, McKay Dee
Medical Center, Ogden, UT.
Labasky,
R.F. May 1998. Therapy for erectile
dysfunction. Medical Staff Grand Rounds, Mercy Medical Center, Nampa,
ID.
Labasky,
R.F. May 1998. Therapy for erectile
dysfunction. Medical Staff Grand
Rounds, St. Luke=s Regional Medical Center, Boise, ID.
Labasky,
R.F. March 1998. Update on BPH
therapy. Medical Staff Grand Rounds, Lakeview Hospital, Bountiful, UT.
Labasky,
R. F. March 1998. Urinary incontinence and the overactive bladder. Obstetrics
and Gynecology Grand Rounds, University of Nevada School of Medicine, Las
Vegas, NV.
Labasky,
R.F. March 1998. Overactive bladder and urge incontinence. Internal Medicine
Grand Rounds, University of Nevada School of Medicine, Las Vegas, NV.
Labasky,
R.F.: July, 1997. Incontinence for
general internists. Internal Medicine
Grand Rounds, University of Utah Health Sciences Center, Salt Lake City, UT
Labasky,
R.F.: April, 1997. Update on impotence treatments. Internal Medicine Grand Rounds, University of Utah Health
Sciences Center, Salt Lake City, UT
Labasky,
R.F.: July, 1995. Evaluation and
treatment of urinary incontinence in primary care. Family Practice Grand Rounds.
University of Utah Health Sciences Center, Salt Lake City, UT.
Labasky,
R.F.: June, 1995. Practical management
of genitourinary problems in patients with neurologic disease. Neurology Grand Rounds. University of Utah Health Sciences Center,
Salt Lake City, UT.
Labasky,
R.F.: April, 1994. Current therapy for BPH - Issues for the internist. Internal
Medicine Grand Rounds, Cottonwood Medical Center, Murray, UT.
Labasky,
R.F.: April, 1994. Emerging therapies for BPH - A urologist's perspective. Urology Grand Rounds. St. Patrick's
Hospital, Missoula, MT.
Labasky,
R.F.: September, 1993. BPH - An approach for the family practice
physician. Family Practice Grand Rounds,
McKay Dee Medical Center, Ogden, UT.
GRAND ROUNDS (Continued)
Labasky,
R.F.: June, 1993. Benign prostatic hyperplasia update. Family Practice Grand
Rounds, Cottonwood Medical Center, Murray, UT.
Labasky,
R.F.: March, 1993. Evaluation and management of bladder dysfunction and incontinence. Grand Rounds, St.
Vincent's Hospital, Billings, MT.
Labasky,
R.F.: February, 1993. Diagnosis and management of urinary incontinence in the
primary care setting. Grand Rounds, Pocatello Regional Medical Center, Pocatello,
ID.
Labasky,
R.F.: February, 1993. Benign prostatic hyperplasia: Etiology, pathophysiology
and current medical management. Grand Rounds, Veteran's Affairs Hospital,
Fresno, CA.
Labasky,
R.F.: February, 1993. Case studies in the treatment of benign prostatic
hyperplasia. Grand Rounds, Valley Medical Center, Fresno, CA.
Labasky,
R.F.: February, 1993. Benign prostatic hyperplasia evaluation and current
medical management. Grand Rounds, Eastern Idaho Regional Medical Center, Idaho
Falls, ID.
Labasky,
R.F., Westenfelder, C.: February, 1993. The many faces of obstructive uropathy.
Internal Medicine Grand Rounds, University of Utah Medical Center, Veteran's
Affairs Medical Center, Salt Lake City, UT.
Labasky,
R.F.: November, 1992. Emerging therapies for benign prostatic hyperplasia.
Sacred Heart Hospital, Eugene, OR.
Labasky,
R.F.: November, 1992. Benign prostatic hyperplasia - Evaluation and new
management approaches. Bay Area Hospital, Coos Bay, OR.
Labasky,
R.F.: November, 1992. Emerging therapies for benign prostatic hyperplasia.
Mercy Medical Center, Roseburg, OR.
Labasky,
R.F.: October, 1992. Emerging therapies for benign prostatic hyperplasia. Grand Rounds Department of Family Practice,
FHP Salt Lake City, UT.
Labasky,
R.F.: October, 1992. Emerging therapies for benign prostatic hyperplasia. Grand Rounds, Bannock Regional Medical
Center, Pocatello, ID.
Labasky,
R.F.: June, 1991. Clinical diagnosis and treatment of incontinence. Department of Family and Preventive
Medicine, Grand Rounds, University of Utah Medical Center.
Labasky,
R.F.: April, 1991. BPH-New therapeutic options. Hill AFB Hospital Grand Rounds.
GRAND ROUNDS (Continued)
Labasky,
R.F.: March, 1991. The evaluation and treatment of impotence. Department of Neurology, Grand Rounds,
University of Utah Medical Center.
Labasky,
R.F.: November, 1990. Urological diagnosis and management of the neuropathic
bladder. Grand Rounds, Department of Neurology, University of Utah Medical
Center.
Labasky,
R.F.: September, 1989. Urodynamics and female urology. Utah Urological
Association Meeting.